GENEVA, April 29 -- BIOSOLVIX.,CO.,LTD. (1116-ho, 204, Gasan digital 1-roGeumcheon-guSeoul 08502), ㈜바이오솔빅스 (서울특별시금천구가산디지털1로 204, 1116호) filed a patent application (PCT/KR2024/015696) for "CELL LINE-BASED CANCER ORGANOID AND METHOD FOR EVALUATING DRUG TOXICITY USING SAME" on Oct 16, 2024. With publication no. WO/2025/084780, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s):...